(Q42661950)

English

Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura

scientific article published on 26 May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 November 2017

Addition of cyclophosphamide to steroids provides no benefit compared with steroids alone in treating adult patients with severe Henoch Schönlein Purpura (English)

1 reference

Europe PubMed Central

4 November 2017

Loïc Guillevin

3

object named as

Loic Guillevin

1 reference

Europe PubMed Central

4 November 2017

author name string

Evangéline Pillebout

1

1 reference

Europe PubMed Central

4 November 2017

Corinne Alberti

2

1 reference

Europe PubMed Central

4 November 2017

Amel Ouslimani

4

1 reference

Europe PubMed Central

4 November 2017

Eric Thervet

5

1 reference

Europe PubMed Central

4 November 2017

CESAR study group

6

1 reference

Europe PubMed Central

4 November 2017

language of work or name

0 references

publication date

26 May 2010

1 reference

Europe PubMed Central

4 November 2017

Kidney International

1 reference

Europe PubMed Central

4 November 2017

78

1 reference

Europe PubMed Central

4 November 2017

5

1 reference

Europe PubMed Central

4 November 2017

495-502

1 reference

Europe PubMed Central

4 November 2017

https://scigraph.springernature.com/pub.10.1038/ki.2010.150

0 references

Henoch-Schönlein purpura in adulthood and childhood: two different expressions of the same syndrome

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Henoch-Schönlein purpura in children and adults: clinical differences in a defined population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical update: Henoch-Schönlein purpura

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Henoch-Schönlein purpura in adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment-based literature of Henoch-Schönlein purpura nephritis in childhood

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of corticosteroid on Henoch-Schönlein purpura: a systematic review

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab therapy for severe refractory chronic Henoch-Schönlein purpura.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Schönlein-henoch purpura in children and adults: diagnosis, pathophysiology and management.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Henoch-Schönlein Purpura in adults: outcome and prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Henoch Schönlein purpura with nephritis in adults: adverse prognostic indicators in a UK population

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of outcome in Henoch-Schönlein nephritis in children and adults

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Henoch-Schoenlein nephritis in adults-clinical features and outcomes in Finnish patients

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Elderly-onset Henoch-Schonlein purpura: a case series and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of combination treatment with losartan and trandolapril on office and ambulatory blood pressures in non-diabetic renal disease: a COOPERATE-ABP substudy.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Nomenclature of systemic vasculitides. Proposal of an international consensus conference

1 reference

https://api.crossref.org/works/10.1038%2FKI.2010.150

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/KI.2010.150

1 reference

Europe PubMed Central

4 November 2017

1 reference

Europe PubMed Central

4 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42661950&oldid=1964945758"